Search

Issue
Title
Authors
Personalized approach to systemic treatment of bladder cancer: molecular and genetic markers and new therapeutic strategies (literature review)
Lyubchenko L.N., Ghazaryan K.A., Chernavina K.M., Zaborskiy I.N., Kаryakin O.B., Kaprin A.D.
Narrative review of dissertation research and innovations in Russian science (2012–2024) on malignant kidney tumors
Vorobev V.А., Mickevich D.S., Baklanova O.V., Akperov G.R., Popov I.P.
Prognostic factors of the therapeutic efficacy of mTOR and VEGFR inhibitors in patients with metastatic renal cell carcinoma
Voroshilova Е.А., Apanovich N.V., Nosov D.A., Karpukhin А.V., Sokolova I.N., Fedyanin M.Y.
Neoadjuvant targeted therapy in patients with renal cell carcinoma
Alekseev B.Y., Nyushko K.M., Kalpinsky A.S.
Evaluation of the efficiency of combination palliative treatment in patients with metastatic clear-cell renal cell carcinoma
Borisov P.S., Orlova R.V., Shkolnik M.I., Karlov P.A.
Current idea of an algorithm for drug treatment and optimal succession of using targeted drugs
Nosov D.A., Voroshilova E.A., Sayapina M.S.
OPTIMIZATION OF SECOND-LINE TARGETED THERAPY FOR METASTATIC RENAL CELL CARCINOMA CANCER AFTER USE OF VEGF RECEPTOR – TYROSINE KINASE INHIBITORS (LITERATURE REVIEW)
Savkov R.V.
Pancreatic metastases from renal cancer: comparing surgery and pharmacotherapy efficacy
Kotelnikov A.G., Kriger A.G., Podluzhny D.V., Proskuryakov I.S., Galkin G.V., Patyutko Y.I., Fainstein I.A.
Results and analysis of the application of a consistent targeted therapy in patients with metastatic renal cell carcinoma in Moscow (for the period from June 2005 to July 2015)
Shirokorad V.I., Kolesnikov G.P., Kostritskiy S.V., Kashintsev K.Y., Dolgikh D.V.
Sorafenib is the first targeted agent to treat metastatic kidney cancer
Matveev V.B., Chernyaev V.A.
PROGNOSTIC VALUE OF MOLECULAR GENETIC MARKERS IN KIDNEY CANCER PATIENTS RECEIVING TARGETED THERAPY
Peters M.V., Shevchenko V.E., Matveev V.B., Volkova M.I., Kalinin S.A., Mikhailenko D.M., Zaletayev D.V.
Current advances in kidney cancer immunotherapy
Korotaeva A.A., Apanovich N.V., Braga E.A., Matveev V.B., Karpukhin A.V.
Lenvatinib in combination with everolimus in metastatic renal cell carcinoma resistant to antiangiogenic targeted therapy: an initial Russian experience
Volkova M.I., Evsyukova O.I., Olshanskaya A.S., Matveev V.B.
Combined treatment of metastatic renal cell carcinoma in spine
Shirokorad V.I., Kostritskii S.V., Zaborovskiy N.S., Ptashnikov D.A.
Clinical economic assessment of the use of pazopanib in the therapy of disseminated kidney cancer
Zyryanov S.K., Frolov M.Y., Dyakov I.N.
A case of treatment in a patient with synchronous bilateral renal cell carcinoma and simultaneous metastatic involvement of both adrenal glands: Clinical observation
Latypov V.R., Dambaev G.T., Popov O.S., Latypova V.N.
SEQUENTIAL TARGETED THERAPY FOR DISSEMINATED KIDNEY CANCER
Matveev V.B., Volkova M.I.
Assessment of kidney injury during immune-targeted therapy (pembrolizumab + axitinib) in patients with metastatic renal cell carcinoma and solitary kidney
Titov K.S., Epifanova M.V., Alimov A.A., Shutov E.V., Nesterova O.Y., Lebedev S.S., Zapirov G.M.
Capabilities of preoperative targeted therapy in treatment of bone metastases in renal cancer
Yurmazov Z.A., Lushnikova N.A., Spirina L.V., Usynin E.A., Slonimskaya E.M., Anisenya I.I., Bogoutdinova A.V.
Review of the Proceedings of the European Society for Medical Oncology (ESMO) 2017 Congress
Kirichek A.A., Kamolov B.S., Matveev V.B.
Use of sunitinib in patients with metastatic kidney cancer in real clinical practice
Alekseev B.Y., Nyushko K.M., Kalpinsky A.S.
Axitinib in the successive targeted therapy of patients with metastatic kidney cancer
Alekseev B.Y., Kalpinsky A.S., Nyushko K.M., Kaprin A.D.
Nephrotoxicity of combination drug therapy in metastatic renal cancer
Titov K.S., Shutov E.V., Alimov A.A., Lebedev S.S., Kirichek A.A., Zapirov G.M.
Review of the proceedings of the 2019 Genitourinary Cancers Symposium of the American society of clinical oncology (ASCO GU 2019)
Kirichek A.A.
Metastatic renal cell carcinoma kidney in children 10 years old – possibility of targeted therapy
Pavlov A.Y., Sabirzyanova Z.R., Zheludkova O.G., Mikhalchenko A.V.
Current treatment approach to non-clear cell renal carcinoma
Tsimafeyeu I.V.
Metastatic kidney cancer: Choice of first-line therapy
Alekseev B.Y.
USE OF A COMBINATION OF АVASTIN AND LOW-DOSE INTERFERON- α IN THE FIRST-LINE TREATMENT OF METASTATIC RENAL-CELL CANCER
Kalpinsky A.S., Alekseyev B.Y., Kaprin A.D.
Biomarkers determining treatment tactics in metastatic urothelial cancer
Grivtsova L.Y., Karyakin O.B., Syadrin M.G., Samborsky S.M., Ivanov S.A., Kaprin A.D.
Therapeutic effects of pazopanib treatment in patients with metastatic kidney cancer in real clinical practice
Berezin P.G., Milovanov V.V., Ivannikov A.A., Ognerubov N.A.
Possibilities of optimization of the second line targeted therapy for metastatic renal cell carcinoma
Markova A.S., Matveev V.B.
Optimization of sequential targeted therapy
Alekseev B.Y., Kalpinskiy A.S., Nyushko K.M., Taraki I.A., Kaprin A.D.
THE FIRST RESULTS OF TARGETED THERAPY FOR KIDNEY CANCER IN MOSCOW
Shirokorad V.I., Makhson A.N., Borisov V.I., Minakova L.R., Popov M.I., Shchupak M.Y., Kirdakova N.V., Mishugin S.V., Maturov M.R., Vinogradsky A.G., Shikhov S.D., Gaidamaka E.V., Apolskaya N.A., Shushakov M., Babaev E.R., Vorontsova A.A., Ivanov A.M., Amosov F.R., Kolesnikov G.P.
Renal cell carcinoma: What’s new in 2018
Matveev V.B., Markova A.S.
Clinical experience in using sorafenib in patients with advanced kidney cancer
Zyryanov A.V., Oshchepkov V.N., Burkhanova L.A.
A new alternating regimen in metastatic renal cell carcinoma presented through a clinical case
Sayapina M.S., Shiryaev S.V., Krylov A.S., Ryzhkov A.D., Titov D.A., Nosov D.A.
Palliative nephrectomy until targeted therapy of disseminated kidney cancer patients
Klimov A.V., Volkova M.I., Shirokograd V.I., Kalinin S.A., Peters M.V., Matveev V.B.
IDENTIFICATION OF PROGNOSTIC FACTORS OF THE EFFICIENCY OF BEVACIZUMAB THERAPY IN PATIENTS WITH METASTATIC RENAL-CELL CANCER
Alekseyev B.Y., Kalpinsky A.S., Nyushko K.M., Klimenko A.A., Anzhiganova Y.V., Varlamov S.A., Bichurina S.A., Vasilyev L.A., Arkhipov A.V., Gurina L.I., Leonov O.V.
CURRENTLY AVAILABLE TREATMENT OPTIONS FOR METASTATIC RENAL CELL CARCINOMA
Alekseev B.Y., Kaprin A.D., Kolesnikov G.P., Mukhomed’yarova A.A., Konopleva E.I., Kalpinskiy A.S.
Targeted therapy of advanced renal cell carcinoma
Popov A.M.
Efficiency and safety of the everolimus in patients with the generalized renal cell carcinoma (multicentral observational study)
Volkova M.I., Nosov D.A., Chernyaev V.A., Voroshilova E.A., Sayapina M.S., Kolesnikov G.P., Leonenkov R.V., Khvorostenko D.A., Borisov P.S., Shushakov M.U., Kirdakova N.V., Alekseev B.Y., Matyash M.G.
EFFICIENCY OF TARGETED THERAPY USED IN THE HETEROGENEOUS POPULATION OF PATIENTS WITH METASTATIC KIDNEY CANCER
Alekseev B.Y., Kalpinsky A.S.
USE OF TARGET DRUGS IN A HETEROGENEOUS POPULATION OF PATIENTS WITH METASTATIC KIDNEY CANCER
Alekseev B.Y., Kalpinskiy A.S.
Renal cell carcinoma: what’s new in 2019
Evsyukova О.I., Matveev V.В.
Individual approach in choosing second-line targeted therapy for metastatic renal cell carcinoma
Alekseev B.Y., Shevchuk I.M., Kaprin A.D.
Targeted therapy in patients with poor-prognosis renal cell carcinoma
Alekseev B.Y., Kalpinskiy A.S., Mukhomed’yarova A.A., Nyushko K.M., Kaprin A.D.
Interim results of targeted therapy of patients with metastatic kidney cancer in Moscow (for the period from June 2005 to July 2015)
Shirokorad V.I., Makhson A.N., Rusakov I.G., Kolesnikov G.P., Kostritskiy S.V., Kashintsev K.Y., Borisov V.I., Popov M.I., Shchupak M.Y., Kirdakova N.V., Mishugin S.V., Maturov M.R., Vinogradskiy A.G., Shikhov S.D., Gaydamaka E.V., Apol’skaya N.A., Shushakov M.U., Babaev E.R., Vorontsova A.A., Ivanov A.M., Amosov F.R.
PROGNOSTIC VALUE OF VHL GENE ALTERATION IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA
Nosov D.A., Yakovleva E.S., Fedyanin M.Y., Chekini D.A., Sinitsyna M.N., Savelov N.A., Mikhailenko D.S., Zaletayev D.V., Lyubchenko L.N., Tjulandin S.A.
1 - 48 of 48 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"